Amparo García-Burillo

[177Lu]Lu-DOTA-TATE plus long-acting octreotide versus high‑dose long-acting octreotide for the treatment of newly diagnosed, advanced grade 2–3, well-differentiated, gastroenteropancreatic neuroendocrine tumours (NETTER-2): an open-label, randomised, phase 3 study

Simron Singh, Daniel Halperin, Sten Myrehaug et al. · The Lancet · 2024 · 250 citations · Full text

Grade 2–3, Endocrine Oncology, Long-acting Octreotide +10

Diagnostic accuracy of technetium-99m-MIBI myocardial SPECT in women and men.

C Santana-Boado, Jaume Candell‐Riera, Joan Castell‐Conesa et al. · PubMed · 1998 · 102 citations

Simultaneous Dipyridamole/Maximal Subjective Exercise With 99mTc-MIBI SPECT: Improved Diagnostic Yield in Coronary Artery Disease

Jaume Candell‐Riera, César Santana-Boado, Joan Castell‐Conesa et al. · Journal of the American College of Cardiology · 1997 · 83 citations

Kinesiology, Health Sciences, Cardiovascular Disease +11

Efficacy of [177Lu]Lu-DOTATATE in metastatic neuroendocrine neoplasms of different locations: data from the SEPTRALU study

Mercedes Mitjavila, Paula Jiménez‐Fonseca, Pilar Belló et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2023 · 52 citations · Full text

SPECT/CT sentinel lymph node identification in papillary thyroid cancer: lymphatic staging and surgical management improvement

Amparo García-Burillo, Isabel Bielsa, Óscar González et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2013 · 37 citations

Papillary Thyroid Cancer, Thyroid Disease, Lymphatic Staging +2